NCT03954015 - Comparison of Three Methods for Early Detection of Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

October 5, 2021

Conditions

Proliferative Breast Disease

Interventions

DIAGNOSTIC_TEST

Contrast Enhanced imaging

Contrast Enhanced Ultrasound (CEUS) with US Microvessel Imaging, Contrast Enhanced Dual Energy Mammography (CEDM) and Contrast Enhanced Breast MR (CEMR): Comparison of Three Methods for Early Detection of Breast Cancer.

DRUG

Lumason

FDA approved and used routinely for ultrasound exams of the heart and liver as well as the urinary tract in children. It contains microbubbles that are small enough to pass through the blood stream.

Trial Locations (1)

55905

Mayo Clinic, Rochester